Recruiting studies: Cardiomegaly

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

The Application of T1 Mapping in Real-World
Phase N/A · 1 location(s) · Chinese Academy of Medical Sciences, Fuwai Hospital · NCT07354646 Study of LX2006 Gene Therapy in Friedreich Ataxia Cardiomyopathy
Phase 2 · 1 location(s) · Lexeo Therapeutics · NCT07721025 Molecular and Imaging Studies of Cardiovascular Health and Disease
Phase N/A · 1 location(s) · National Heart Centre Singapore · NCT02804269 Fish Oil, Metformin and Heart Health in PCOS
Phase 1 · 3 location(s) · University of Alberta · NCT06424860 Cardiac Magnetic Resonance-Clinical Prediction Model-Dilated Cardiomyopathy
Phase N/A · 1 location(s) · Shandong Provincial Hospital · NCT07527715 Outcome-targeted Therapy: Principle and Outcome Evaluation: Clinical Study and Phenotype-genotype Correlation
Phase 2 · 1 location(s) · National Taiwan University Hospital · NCT06632834 The Effects of Sirolimus in Patients With Dilated Cardiomyopathy Infected With Kaposi Sarcoma-associated Virus
Phase 4 · 1 location(s) · Tongji Hospital · NCT06236022 Sodium Glucose Co-Transporter 2 (SGLT2) and STEMI
Phase 2 · 1 location(s) · Minneapolis Heart Institute Foundation · NCT05305911 Protein A Immunoadsorption in Dilated Cardiomyopathy (RPIA-DCM)
NA · 1 location(s) · Union Hospital, Tongji Medical College, Huazhong University · NCT06922851 Austrian Hypertrophic Cardiomyopathy Registry
Phase N/A · 15 location(s) · Medical University of Graz · NCT06368518 A Phase 1 Open-Label Study of the Safety of Intravenous Allogeneic Neonatal Mesenchymal Cells (nMSCs) in Young Adult (1A
Phase 1 · 5 location(s) · Emory University · NCT06464588 AI-Enabled Direct-from-ECG Ejection Fraction (EF) Severity Assessment Using COR ECG Wearable Monitor
Phase N/A · 8 location(s) · Peerbridge Health, Inc · NCT06699056 Evaluation of the Efficacy of Diagnostic Support Algorithms in Chest X-rays- LuAna Trial
NA · 1 location(s) · Hospital Israelita Albert Einstein · NCT06686251 Postnatal Steroids Effects on Cardiac Function in Extremely Preterm
Phase N/A · 1 location(s) · McGill University Health Centre/Research Institute of the Mc · NCT04644094 Safety and Efficacy of Second Infusion of FAP iCDC in End-stage Dilated Cardiomyopathy
Phase 1 · 1 location(s) · Second Affiliated Hospital, School of Medicine, Zhejiang Uni · NCT07516288 An AAV Gene Therapy Trial of AFTX-201 in Adults With BAG3-Associated Dilated Cardiomyopathy (DCM)
Phase 1/Phase 2 · 3 location(s) · Affinia Therapeutics · NCT07426419 Therapy to Maintain Remission in Dilated Cardiomyopathy
NA · 1 location(s) · Imperial College London · NCT06091475 Triple Combination Therapy (ARNI, SGLT2i, MRA) in Advanced HFpEF
Phase 2 · 1 location(s) · National Medical Research Center for Cardiology, Ministry of · NCT06655480 Modifying Factors in Striated Muscle Laminopathies
NA · 8 location(s) · Institut National de la Santé Et de la Recherche Médicale, F · NCT05394506 Cardiac Magnetic Resonance for Risk Stratification in Dilated Cardiomyopathy
Phase N/A · 1 location(s) · Chinese Academy of Medical Sciences, Fuwai Hospital · NCT04990297 Study of the Progression of Chronic Cardiovascular Conditions
Phase N/A · 1 location(s) · Prolaio · NCT07420907 Early Treatment With Candesartan vs Placebo in Genetic Carriers of Dilated Cardiomyopathy (EARLY-GENE Trial)
Phase 3 · 1 location(s) · Cristina Avendaño Solá · NCT05321875 Characterization of Patients With Cardiomyopathy to Identify Critical Patients Candidates for Cardiac Transplantation
Phase N/A · 3 location(s) · IRCCS Azienda Ospedaliero-Universitaria di Bologna · NCT06813443 Microvascular Dysfunction Assessment to Predict Left Ventricular Reverse Remodeling
NA · 9 location(s) · Azienda Ospedaliera Universitaria Integrata Verona · NCT06356727 Bromocriptine in Dilated Cardiomyopathy Among Women of Reproductive Age
Phase 3 · 1 location(s) · Jimma University · NCT06250257 Coronary Artery Disease and Coronary Microvascular Disease in Cardiomyopathies Registry
Phase N/A · 1 location(s) · University Hospital, Grenoble · NCT03479580 MEK Inhibitors for the Treatment of Hypertrophic Cardiomyopathy in Patients With RASopathies
Phase 2 · 1 location(s) · Medical University of Warsaw · NCT06555237 Mineralocorticoid Receptor, Coronary Microvascular Function, and Cardiac Efficiency in Hypertension
Phase 4 · 1 location(s) · Brigham and Women's Hospital · NCT05593055 the Clinical Outcome of Empagliflozin in Pediatric Heart Failure Patients
Phase 2 · 1 location(s) · Ain Shams University · NCT07692256 The SMARTER Cardiomyopathy Study
Phase N/A · 2 location(s) · Imperial College London · NCT05750147

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.